Tuesday, October 3, 2006

Mirabilis Names CEO

Seattle-based Mirabilis Medica has named a new President and CEO, saying today that it has appointed Mike Connolly to the position. Founder and current CEO Michael Lau will become the firm's Chief Medical Officer and Chairman. Connolly joins the firm from vSpring Capital, a venture capital firm, where he was principal. Connolly has also cofounded Novacept and Cohesion Technologies, two biomedical companies. Mirabilis is developing medical devices based on high-intensity focused ultrasound. vSpring is an investor in the firm, along with Charter Life Sciences. The company is based on technology out of the University of washington. More information »